by James Templeton | Mar 8, 2026 | Articles
How did a $7 dog dewormer ignite a global conversation about cancer treatment—and what does the Joe Tippens story reveal about fenbendazole, ivermectin, and the science behind these repurposed compounds?
by Ben Clark | Feb 11, 2026 | Expert Interviews
James Templeton sits down with John A. Richardson, Jr. to explore one of the most debated chapters in integrative cancer history: amygdalin — also known as vitamin B-17 or laetrile.
by Ben Clark | Jan 2, 2026 | Expert Interviews
James Templeton sits down with integrative cancer physician Dr. Kathy Goldsworthy to explore a radically different way of thinking about cancer treatment—one that focuses on outsmarting cancer rather than simply attacking it.
by Ben Clark | Sep 23, 2025 | Expert Interviews
James Templeton sits down with Dr. Anthony Macasieb for a candid discussion on what doctors really learn in medical school about cancer—its origins, its treatment, and what often gets left out.
by James Templeton | Sep 8, 2024 | Articles
Ever since I interviewed Oklahoma businessman Joe Tippens about his legendary recovery from Stage 4 lung cancer, readers want to know more about the protocol.